We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $100M
This Fund
S&P 500
This Quarter Est. Return
+3.46%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$368M
AUM Growth
+$71.7M
Cap. Flow
+$61.6M
Cap. Flow %
16.74%
Top 10 Hldgs %
80.73%
Holding
256
New
50
Increased
99
Reduced
30
Closed
47

Top Buys

Rank Stock Value
1
MBB icon
iShares MBS ETF
MBB
+$24.9M
2
VMBS icon
Vanguard Mortgage-Backed Securities ETF
VMBS
+$23M
3
RITM icon
Rithm Capital
RITM
+$2.6M
4
TVTX icon
Travere Therapeutics
TVTX
+$1.21M
5
OUST icon
Ouster
OUST
+$907K

Top Sells

Rank Stock Value
1
RAVN
Raven Industries Inc
RAVN
+$1.53M
2
LAZR
Luminar Technologies
LAZR
+$1.22M
3
QURE icon
uniQure
QURE
+$1.09M
4
NUAN
Nuance Communications, Inc.
NUAN
+$1.09M
5
UAVS icon
AgEagle Aerial Systems
UAVS
+$783K

Sector Composition

Rank Sector Weight
1 Real Estate 18.83%
2 Healthcare 12.69%
3 Technology 1.7%
4 Industrials 0.97%
5 Financials 0.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IDYA icon
226
IDEAYA Biosciences
IDYA
$3.41B
– –
-10,000
Closed -$235K
IVZ icon
227
Invesco
IVZ
$13.1B
– –
-19,943
Closed -$503K
KSS icon
228
Kohl's
KSS
$1.99B
– –
-11,299
Closed -$674K
LAZR
229
DELISTED
Luminar Technologies
LAZR
– –
-3,333
Closed -$1.22M
LEGN icon
230
Legend Biotech
LEGN
$4.49B
– –
-20,000
Closed -$580K
LLY icon
231
Eli Lilly
LLY
$1.02T
– –
-283
Closed -$53K
MGM icon
232
MGM Resorts International
MGM
$11.9B
– –
-13,088
Closed -$497K
NBIX icon
233
Neurocrine Biosciences
NBIX
$17.4B
– –
-2,000
Closed -$195K
OSCR icon
234
Oscar Health
OSCR
$8.92B
– –
-5,500
Closed -$148K
PFG icon
235
Principal Financial Group
PFG
$24.2B
– –
-6,283
Closed -$377K
QURE icon
236
uniQure
QURE
$2.73B
– –
-32,500
Closed -$1.09M
TUR icon
237
iShares MSCI Turkey ETF
TUR
$207M
– –
-3,547
Closed -$82K
UAVS icon
238
AgEagle Aerial Systems
UAVS
$43M
– –
-125
Closed -$783K
UNM icon
239
Unum
UNM
$14.2B
– –
-12,633
Closed -$352K
VLO icon
240
Valero Energy
VLO
$93B
– –
-3,674
Closed -$263K
WMT icon
241
Walmart Inc
WMT
$893B
– –
-1,008
Closed -$46K
YMAB
242
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-22,000
Closed -$665K
ZNTL icon
243
Zentalis Pharmaceuticals
ZNTL
$357M
– –
-5,000
Closed -$217K
ZYME icon
244
Zymeworks
ZYME
$1.75B
– –
-6,000
Closed -$189K
ASXC
245
DELISTED
Asensus Surgical, Inc.
ASXC
– –
-150,000
Closed -$488K
GRCL
246
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
– –
-19,000
Closed -$293K
RETA
247
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-2,500
Closed -$249K
LHDX
248
DELISTED
Lucira Health, Inc. Common Stock
LHDX
– –
-17,000
Closed -$206K
CTXS
249
DELISTED
Citrix Systems Inc
CTXS
– –
-290
Closed -$41K
NUAN
250
DELISTED
Nuance Communications, Inc.
NUAN
– –
-25,000
Closed -$1.09M
7 8 9
10
11

Similar funds

WCM
Weber Capital Management San Francisco, California $100M AUM
FCM
Fourier Capital Management Hong Kong $100M AUM
BIA
Baer Investment Advisory Corte Madera, California $100M AUM 23.87% 1-Year Est. Return
AGAM
Audent Global Asset Management West Hollywood, California $100M AUM 22.83% 1-Year Est. Return
E
Entelevest Coral Gables, Florida $100M AUM
HCM
Hicks Capital Management Columbus, Ohio $100M AUM 14.29% 1-Year Est. Return
AC
Arrow Capital Sydney, Australia $100M AUM 68.52% 1-Year Est. Return
OIS
OneAscent Investment Solutions Birmingham, Alabama $100M AUM 15.97% 1-Year Est. Return

AlphaCentric Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, AlphaCentric Advisors held 256 positions worth $368M, up 24% from $297M the previous quarter. Its ten largest holdings account for 81% of the portfolio.

AlphaCentric Advisors deployed $61.6M of net new capital in Q2 2021, opening 50 new positions and adding to 99 existing holdings. Its largest new stake was Rithm Capital: 245,158 shares worth $2.6M.

By sector, the portfolio is most concentrated in Real Estate at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Azenta, an estimated $485K trimmed.

  • AlphaCentric Advisors's largest Q2 2021 buy was Rithm Capital: 245,158 shares worth $2.6M.
  • AlphaCentric Advisors added most to iShares MBS ETF in Q2 2021, an estimated $24.9M increase.
  • AlphaCentric Advisors's biggest Q2 2021 reduction was Azenta, cutting an estimated $485K.
  • AlphaCentric Advisors fully exited Raven Industries Inc in Q2 2021, selling an estimated $1.53M.
  • AlphaCentric Advisors's ten largest holdings make up 81% of its $368M portfolio in Q2 2021.
  • AlphaCentric Advisors opened 50 new positions and closed 47 in Q2 2021.
  • AlphaCentric Advisors's portfolio value rose 24% quarter-over-quarter to $368M.

Based on AlphaCentric Advisors's 13F filing for Q2 2021, filed 9 Mar 2022.